Dr. Jou, Yuh-Shan
Distinguished Research Fellow
- 27899062,26523525(Lab) (Lab) (Room No: N606)
- 26523521(O)
- 27827654 (Fax)
-
Specialty:
- Cancer Genomics
- Molecular Cancer Biology
- Bioinformatics
Education and Positions:
Ph.D., Michigan State University
Highlight Detail
Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.
Dr. Jou, Yuh-Shan
Hepatology., Mar 04, 2013Eukaryotic translation initiation factor 3 subunit I (eIF3I) with transforming capability is often overexpressed in human hepatocellular carcinoma (HCC) but its oncogenic mechanisms remain unknown. We demonstrate that eIF3I is overexpressed in various cancers along with activated Akt1 phosphorylation and kinase activity in an eIF3I dose-dependent manner.